The skeletal ryanodine receptor 1 (RYR1) is a calcium release channel that is essential for excitation-contraction coupling in the sarcoplasmic reticulum of skeletal muscles. 1 Mutations in the RYR1 gene cause RYR1 protein dysfunction which clinically manifests in a wide spectrum of disease phenotypes of varying symptoms, disease onset and severity. Autosomal dominant mutations cause susceptibility to malignant hyperthermia (MHS) or RYR1-related congenital myopathies such as multi-minicore disease, central core disease (OMIM # 117000) and core-rod myopathy, with the latter two reported to be lethal. 2, 3 Recessively inherited variants have been described to manifest during fetal development. The lethal multiple pterygium syndrome (LMPS, OMIM # 253290) presenting with fetal akinesia during pregnancy represents the lethal end of the spectrum of RYR1 associated phenotypes. 4 The study was approved by the Ethics Commission Northwest Switzerland (EKNZ 2014-174) . Written informed consent for participation and publication of clinical data and photos were obtained from the participants.
We report on a non-consanguineous family of Turkish descent who had a reproductive history of one early miscarriage, the birth of two healthy daughters and a fourth pregnancy terminated for fetal hydrops without further investigations. The parents came to our attention after their fifth pregnancy for which the mother reported phenotype recurrence. After she had noticed reduced fetal movement, an ultrasound scan confirmed multiple contractures and hydrops fetalis. The fetus died in utero at the 24th week of gestation. High-resolution chromosomal microarray did not reveal a causal chromosomal abnormality. The post-mortem examination of the fetus confirmed fetal hydrops and bilateral flexion contractures of the joints of the limbs as well as bilateral clubfeet (Figure 1a) . Mild pterygia were recognizable in the elbow joints. Autopsy revealed a pronounced generalized hypoplasia of the skeletal muscle tissue including the diaphragm (Figure 1b ). Myocardial and esophageal muscles ( Figure 1c) were hypoplastic as well. The small intestine showed a 'string of beads' like structure (Figure 1d ) with hypertrophy of the walls and alternating hypoplastic segments of thin smooth muscle layers. Due to the finding of a significant generalized hypoplasia of skeletal and smooth muscles, we hypothesized a primary defect of muscle development, leading to the prenatal clinical presentation of arthrogryposis and hydrops in the fetus. Lethality of the condition and potential phenotype recurrence based on the reproductive history suggested an autosomal recessive condition. 5 In order to delineate the etiology, we performed familybased whole exome sequencing (WES) using the trio of fetal DNA extracted from formalin fixed paraffin embedded (FFPE) tissue and parental DNA extracted from blood samples. Tissue or DNA from the previous affected pregnancy was not available.
Library preparation was performed with the Agilent SureSelect XT Library Prep Kit and enriched with Agilent SureSelect XT Human All Exon V6 (Agilent, Santa Clara, California). Paired-end read sequencing (2x100bp read length) was accomplished on a HiSeq 2500 platform (Illumina, San Diego, CA). Mapping to the reference genome sequence (hg19) and alignment were carried out using Burrows-Wheeler Aligner (BWA-mem Version 0.7.2). Alignments with a Phred quality score below 30 for the entire read and potential PCR duplicates were discarded using samtools (Version 0.1.18). To get a high sensitivity, variant calling was performed with samtools and varscan (Version 2.3.5). Hypothesizing a rare Mendelian disorder, we annotated variants as known or novel according to the presence or absence in curated databases. Variants were filtered on a heterozygous population frequency (GMAF) of <5% in control databases (dbSNP142, ExAC, 1000G, gnomAD) and absence of homozygosity in healthy individuals (ExAC). We prioritized variants according to their potential to disrupt protein function including the use of prediction tools (SIFT, Provean, Polyphen2, Mutationtaster, Human Splicing Finder v.3.0), the amino acid conservation (PhyloP, PhastCons) and the American College of Medical Genetics (ACMG) variant classification guidelines. 6 Prioritized variants were inspected for phenotype-genotype correlations reported in humans and other species, based on the medical literature and public databases including functional and expression data (Pubmed, ClinVar, OMIM, HGMD, Uniprot, UniGene, www.zfin.org; www.informatics.jax.org; www.mousephenotype.org).
We prioritized a homozygous splice acceptor-site mutation in the RYR1 gene at position c.9686-1G > C (NM_001042723.1, chr19:39007998, hg19) as the best candidate out of three homozygous and 28 compound heterozygous mutations. We chose this variant because (1) it was the only truncating mutation, (2) it was absent in any of the databases and therefore novel, (3) it is located in a gene playing a role in muscle development and function and (4) database and literature search identified mutations in the same gene, causing similar phenotypes in humans and other species. Other variants were predicted to be functionally benign, within genes of unknown function without correlation to the phenotype or related pathways. Two homozygous variants in the COL6A3 gene were reported in a homozygous state in healthy individuals (ExAC database). The novel RYR1 variant identified is situated in the 3 0 splice-site of exon 66 and is predicted to cause alternative splicing (HSF 3.0, Mutation Taster). According to the ACMG guidelines, the mutation fulfills the criteria for a very strong evidence of pathogenicity (PVS1, PS3, PM2, PP3, PP4). 6 Sanger sequencing using standard polymerase chain reaction (PCR) amplification procedures confirmed homozygosity in the fetus (Figure 1f ) and heterozygosity in both unaffected parents. The mutation is located in a 5.37 Mb region of absence of heterozygosity (AOH) in the fetus (ngCGH, Nexus copy number software, Bio discovery). However, the proportion of the autosomal genome (0.9% for stretches of homozygosity >5 Mb) does not indicate consanguinity. 7 In order to confirm the mutational impact on the RYR1 transcript, whole RNA from skeletal muscle FFPE tissue of the affected fetus, and an age-matched control tissue was extracted following the protocol of the RecoverAll ™ Kit (Ambion, Thermo Fisher Scientific, Waltham, Massachusetts).
Reverse transcription was performed with the SuperScript® VILO cDNA Synthesis Kit (Thermo Fisher Scientific, Waltham, Massachusetts) and accomplished with the Taq DNA Polymerase Kit (Qiagen, Germantown, Maryland). Sanger sequencing confirmed correct exon sequences. Analysis of exons 64-67 of the RYR1 gene showed their absence in the affected fetus (Figure 1g ). Nonsense medicated decay was excluded by the presence of exon 20 and 90 (data not shown) indicating that alternative splicing, leading to an aberrant protein by exon skipping, is the likely mechanism. Because exon 66 encodes amino acids in the α-Solenoid 2 domain of the RYR1 protein which is part of the machinery that reacts to conformational changes to open the receptor for calcium efflux, 8 the α-Solenoid 2 domain is likely misfolded and functionally impaired. Hydrops fetalis is a well-known fetal phenotype, and its etiology is highly heterogeneous, but was -so far -not necessarily linked to congenital disorders of muscle development. 9 We describe a fetus diagnosed with hydrops fetalis for which post-mortem examination identified impaired skeletal and smooth muscle development to be the underlying condition caused by the novel homozygous splice site mutation c. 9686-1G > C in the 3 0 splice-site of exon 66 in the RYR1 gene. Due to the sparsity of the muscle tissue and its autolysis, we were not able to further investigate histopathological signs of core-rod or other RYR1 related myopathies. Lethal phenotypes caused by recessively inherited mutations in the RYR1 gene presenting with hypoplasia of skeletal muscles have been rarely documented, and in only half of these patients, a fetal hydrops has been reported. A detailed phenotypic comparison is shown in Table 1 . In all but one of these patients, at least one of the mutations in RYR1 is truncating, and in only one patient a compound heterozygous splice site mutation has been reported. 10 Mutations in the RYR1 gene causing the LMPS phenotype have been described in three studies so far. 4, 10, 11 The RYR1 receptor is expressed in the skeletal muscle tissue in humans, but its expression in smooth muscle tissue has been demonstrated in rats.
14 For the first time, we report here on the finding of hypoplastic smooth muscle tissue in humans caused by RYR1 mutations (Table 1 and Figure 1a-d) . Thus, dysfunction of the RYR1 protein does not only impair skeletal muscle development but also primarily affects the development of smooth muscle, which previously was often attributed to the absence of movement. In the dyspedic knock-out mouse-model 15 a homozygous mutation in the RYR1 gene causes a complete loss of function of the protein resulting in a comparable phenotype. Homozygous mice show cystic hygroma and skeletal muscle hypoplasia including hypoplastic diaphragm, leading to perinatal death. The effect on the expression of over 300 genes (up-or down-regulation), 16 including components of the MAPK signaling pathway, the Wnt-signaling pathway as well as Gprotein coupled receptors, illustrates the important role of this receptor in early human development. Twenty-one genes were identified as related to muscle functionality such as muscle force production and contraction, and another 22 were related to structural features of muscle tissue. Because the absence of the RYR1 channel affects many developmental pathways, this protein may be more important to early fetal development and phenotype diversity than currently thought. In the presence of fetal hydrops, a congenital muscle disease, which is often difficult or not possible to assess by ultrasound, should be considered. RYR1 should be added to the panels of diagnostic sequencing for severe fetal disorders.
WHAT'S ALREADY KNOWN ABOUT THIS TOPIC?
• Mutations in the RYR1 gene can cause variable phenotypes including autosomal dominant malignant hyperthermia, multiminicore disease, core-rod myopathy and autosomal recessive lethal multiple pterygium syndrome at the severe end of the spectrum.
WHAT DOES THIS STUDY ADD?
• Autosomal recessive mutations in RYR1 cause non-immune fetal hydrops more often than previously thought. These mutations affect skeletal muscle development but also impact smooth muscle tissue in early human development. RYR1 should be added to sequencing panels in prenatal diagnostics.
